Grafnos 2.0 Capsule

Produktübersicht

About Grafnos 2.0

Grafnos 2.0 is a medication containing the active ingredient Tacrolimus, classified as Immunosuppressive drug. Tacrolimus, sold under the brand name Prograf among others, is an immunosuppressive drug. After an allogenic organ transplant, the risk of organ rejection is moderate; tacrolimus is used to lower the risk of organ rejection.

Key Benefits & Uses

• Used for: 1 INDICATIONS AND USAGE Tacrolimus extended-release capsules is indicated for the prophylaxis of organ rejection in kidney transplant patients in.
• Use only as directed on the product label or by a healthcare professional.
• Follow the authorised product information for dosing and duration of use.

Active Ingredient & Action

Tacrolimus, the active ingredient in Grafnos 2.0, belongs to the Immunosuppressive drug class. 1 INDICATIONS AND USAGE Tacrolimus extended-release capsules is indicated for the prophylaxis of organ rejection in kidney transplant patients in combination with other immunosuppressants in adult patients who can swallow capsules intact [see Clinical Studies ( 14. 1 ), ( 14. 2 )] . Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Grafnos 2.0. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Grafnos 2.0 for extended periods without medical advice.